- Home
- NNOX vs TKNO Comparison
NNOX vs TKNO Comparison
Compare NNOX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNOX | TKNO |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 138.1M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NNOX | TKNO |
|---|---|---|
| Price | $2.21 | $2.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 593.1K | 131.6K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $20.19 | $8.27 |
| Revenue Next Year | $137.69 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $2.11 | $1.91 |
| 52 Week High | $5.72 | $7.48 |
Technical Indicators
Market Signals| Indicator | NNOX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 49.36 |
| Support Level | $2.11 | $1.97 |
| Resistance Level | $2.75 | $5.39 |
| Average True Range (ATR) | 0.12 | 0.25 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 6.36 | 34.55 |
Price Performance
Historical ComparisonAbout NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.